Julian Bowen Consort Dining Table, Honey, Height: 77, Width: 92, Depth: 92cm

Product Information

Butcher NJ, Monsour A, Mew EJ, Chan AW, Moher D, Mayo-Wilson E, Terwee CB, Chee-A-Tow A, Baba A, Gavin F, Grimshaw JM, Kelly LE, Saeed L, Thabane L, Askie L, Smith M, Farid-Kapadia M, Williamson PR, Szatmari P, Tugwell P, Golub RM, Monga S, Vohra S, Marlin S, Ungar WJ, Offringa M. Butcher NJ, et al. JAMA. 2022 Dec 20;328(23):2345-2356. doi: 10.1001/jama.2022.21243. JAMA. 2022. PMID: 36512367 Review. Little J, Higgins JPT, Ioannidis JPA, Moher D, Gagnon F, Von Elm E, et al. STrengthening the REporting of Genetic Association studies (STREGA)-an extension of the STROBE Statement. J Clin Epidemiol 2009;62:597e608 Masking (blinding) refers to withholding information about assigned interventions post-randomisation from those involved in the trial [ 46]. Masking can reduce threats to internal validity arising from an awareness of the intervention assignment by those who could be influenced by this knowledge. Authors should state whether and how (a) participants, (b) providers, (c) data collectors, and (d) data analysts were kept unaware of intervention assignment. If masking was not done (e.g. because it was not possible), authors should describe the methods, if any, used to assess performance and expectancy biases (e.g. masking trial hypotheses, measuring participant expectations) [ 82]. Although masking of providers and participants is often not possible, masking outcome assessors is usually possible, even for outcomes assessed through interviews or observations. If examined, authors should report the extent to which outcome assessors remained masked to participants’ intervention status. Item 11b: if relevant, description of the similarity of interventions Shadish WR, Cook TD, Campbell DT. Experimental and quasi-experimental designs for generalized causal inference. Belmont: Wadsworth; 2002. Fraser MW, Galinsky MJ, Richman JM, Day SH. Intervention research: developing social programs. New York: Oxford University Press; 2009.

CONSORT 2010 Explanation and Elaboration: updated - The BMJ

Riley W. New NIH Clinical Trials Policies: Implications for Behavioral and Social Science Researchers. 2016; https://obssr.od.nih.gov/new-nih-clinical-trials-policies-implications-for-behavioral-and-social-science-researchers/. Simera I, Altman DG, Moher D, Schulz K, Hoey J. The EQUATOR Network: facilitating transparent and accurate reporting of health research. Serials 2008 Nov 21 (3): 183-87 Make the perfect match with the Consort chairs, or find your own style with this table that is suitable for mix and match chairs!The dates of a trial and its activities provide readers some information about the historical context of the trial [ 48]. The SPIRIT 2013 Statement includes a table that authors can use to provide a complete schedule of trial activities, including recruitment practices, pre-randomisation assessments, periods of intervention delivery, a schedule of post-randomisation assessments, and when the trial was stopped [ 55]. In the description, authors should define baseline assessment and follow-up times relative to randomisation. For example, by itself, ‘4-week follow-up’ is unclear and could mean different things if meant after randomisation or after the end of an intervention. Item 14b: why the trial ended or was stopped Clinicians, patients, and policy makers rely on published results from clinical trials to help make evidence-informed decisions. To critically evaluate and use trial results, readers require complete and transparent information regarding what was planned, done, and found. Specific and harmonized guidance as to what outcome-specific information should be reported in publications of clinical trials is needed to reduce deficient reporting practices that obscure issues with outcome selection, assessment, and analysis.

CONSORT CHECKLIST - JAMA Network

Glasziou P, Altman DG, Bossuyt P, et al. Reducing waste from incomplete or unusable reports of biomedical research. Lancet. 2014;383(9913):267–76. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. Shamseer L, Hopewell S, Altman DG, Moher D, Schulz KF. Update on the endorsement of CONSORT by high impact factor journals: a survey of journal ‘instructions to authors’ in 2014. Trials. 2016;17(1):301. Authors should provide a balanced discussion of the strengths and limitations of the trial and its results. Authors should consider issues related to risks of bias, precision of effect estimates, the use of multiple outcomes and analyses, and whether the intervention was delivered and taken up as planned. Discussion: generalisability Item 21: generalisability (external validity, applicability) of the trial findings Information about settings and locations of intervention delivery and data collection are essential for understanding trial context. Important details might include the geographic location, day and time of trial activities, space required, and features of the inner setting (e.g. implementing organisation) and outer setting (e.g. external context and environment) that might influence implementation [ 68]. Authors should refer to the mechanism of action when deciding what information about setting and location to report. Methods: interventions Item 5: the interventions for each group with sufficient details to allow replication, including how and when they were actually administered

Betz CL. Adoption of CONSORT statements for randomized control trials published in the Journal of Pediatric Nursing. J Pediatr Nurs. 2011;26(3):177-8. PMID: 21601140 Michie S, Wood CE, Johnston M, Abraham C, Francis JJ, Hardeman W. Behaviour change techniques: the development and evaluation of a taxonomic method for reporting and describing behaviour change interventions (a suite of five studies involving consensus methods, randomised controlled trials and analysis of qualitative data). Health Technol Assess. 2015;19(99):1–187. Authors should provide a table summarising all data collected at baseline, with descriptive statistics for each randomised group. This table should include all important characteristics measured at baseline, including pre-intervention data on trial outcomes, and potential prognostic variables. Authors should pay particular attention to topic-specific information related to socioeconomic and other inequalities [ 88, 89, 90]. For continuous variables, authors should report the average value and its variance (e.g. mean and standard deviation). For categorical variables, authors should report the numerator and denominator for each category. Authors should not use standard errors and confidence intervals for baseline data because these are inferential (rather than descriptive): inferential statistics assess the probability that observed differences occurred by chance, and all baseline differences in randomised trials occur by chance [ 91]. Results: numbers analysed Item 16: for each group, number included in each analysis and whether the analysis was by original assigned groups Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008;337:a1655.

The CONSORT statement - PMC - National Center for The CONSORT statement - PMC - National Center for

Open Science Collaboration. An open, large-scale, collaborative effort to estimate the reproducibility of psychological science. Perspect Psychol Sci. 2012;7(6):657–60.Knottnerus JA, Tugwell P. The standards for reporting of diagnostic accuracy. J Clin Epidemiol 2003;56:1118e27 Abraham C, Michie S. A taxonomy of behavior change techniques used in interventions. Health Psychol. 2007;27:379–87. Hopewell S, Altman DG, Moher D, Schulz KF. Endorsement of the CONSORT statement by high impact factor medical journals: a survey of journal editors and journal ‘Instructions to Authors’. Trials. 2008;9:20. Grant, S., Mayo-Wilson, E., Montgomery, P. et al. CONSORT-SPI 2018 Explanation and Elaboration: guidance for reporting social and psychological intervention trials.

Julian Bowen Consort Dining Table, Honey, Height: 77, Width Julian Bowen Consort Dining Table, Honey, Height: 77, Width

UK glass console tables are a versatile addition to any home, and they can be used as both a decorative feature and a functional piece of furniture in almost any room in the home. If you have a smart study, a chic bedroom or a contemporary living room, an Argos glass console table can provide you with a table to store stationery, display framed photographs or hold vases of flowers, candles or lamps. If you’re keen to impress from the outset, a Next chrome and glass hall table could be an ideal addition to your home. A small console table will work well in a snug or a conservatory. Davidson KW, Goldstein M, Kaplan RM, et al. Evidence-based behavioral medicine: what is it and how do we achieve it? Ann Behav Med. 2003;26(3):161–71. Department of Clinical, Educational and Health Psychology, Centre for Behaviour Change, University College London, London, WC1E 7HB, UK

MacPherson H, Altman DG, Hammerschlag R, et al. Revised STandards for reporting interventions in clinical trials of acupuncture (STRICTA): extending the CONSORT statement. PLoS Med. 2010;7(6):e1000261. Attrition after randomisation can affect internal validity (i.e. by introducing selection bias), and attrition before or after randomisation can affect generalisability [ 46]. Authors should report available information about the total number of participants at each stage of the trial, with reasons for non-enrolment (i.e. before randomisation) or discontinuation (i.e. after randomisation). Key stages typically include: approaching participants, screening for potential eligibility, assessment to confirm eligibility, random assignment, intervention receipt, and outcome assessment. As there may be delays between each stage (e.g. between randomisation and initiation of the intervention) [ 87], authors should include a flow diagram to describe trial attrition in relation to each of these key stages (Fig. 1; Additional file 4) Item 13b: for each group, losses and exclusions after randomisation, together with reasons CONSORT Harms: Junqueira DR, Zorzela L, Golder S, Loke Y, Gagnier JJ, Julious SA, Li T, Mayo-Wilson E, Pham B, Phillips R, Santaguida P, Scherer RW, Gøtzsche PC, Moher D, Ioannidis JPA, Vohra S; CONSORT Harms Group. CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomized trials.